| Absorption |
| Blood-Brain Barrier | BBB- | 0.5633 |
| Human Intestinal Absorption | HIA+ | 0.8530 |
| Caco-2 Permeability | Caco2- | 0.6529 |
| P-glycoprotein Substrate | Substrate | 0.9040 |
| P-glycoprotein Inhibitor | Inhibitor | 0.7478 |
| Non-inhibitor | 0.7130 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6838 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7933 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.6845 |
| CYP450 2D6 Substrate | Non-substrate | 0.5889 |
| CYP450 3A4 Substrate | Non-substrate | 0.6688 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5747 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8370 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.5603 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8180 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.5752 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6580 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9105 |
| Inhibitor | 0.5517 |
| AMES Toxicity | Non AMES toxic | 0.7820 |
| Carcinogens | Non-carcinogens | 0.9077 |
| Fish Toxicity | High FHMT | 0.9215 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9204 |
| Honey Bee Toxicity | Low HBT | 0.7907 |
| Biodegradation | Not ready biodegradable | 0.9902 |
| Acute Oral Toxicity | III | 0.5370 |
| Carcinogenicity (Three-class) | Non-required | 0.6684 |